CNS PHARMACEUTICALS INC
CNSP · NASDAQ
Updated at 2026-10-14 09:31:18
- Today's High
- $5.40
- Today’s Low
- $5.00
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $5.34
- Previous Close
- $5.19
- Volume
- 6.19K
- Market Cap
- $7.58M
- P/E Ratio
- --
- EPS
- $-23.14
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2100 WEST LOOP SOUTH, HOUSTON, TX, UNITED STATES, 77027
- Country
- US
- Listing Date
- 2019-11-08
- Fiscal Year End
- December
- Shares Outstanding
- 1.46M
- CIK
- 0001729427
- Website
- cnspharma.com
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central nervous system tumors. The company is headquartered in Houston, Texas.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$2.7M
2026-03-31
$4.97M
2025-12-31
$5.98M
2025-09-30
$3.25M
Net Income
2026-06-30
-$2.58M
2026-03-31
-$4.93M
2025-12-31
-$5.95M
2025-09-30
-$3.21M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.38
2026-03-31
$-7.30
2025-12-31
$-10.15
2025-09-30
$-5.76
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$2.57M
2026-03-31
-$4.92M
2025-12-31
-$5.95M
2025-09-30
-$3.21M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $2.7M | $4.97M | $5.98M | $3.25M |
| Net Income | -$2.58M | -$4.93M | -$5.95M | -$3.21M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.38 | $-7.30 | $-10.15 | $-5.76 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$2.57M | -$4.92M | -$5.95M | -$3.21M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.